Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | FiercePharma
US Supreme Court sides with Teva in drug dispute
Teva Stops Production At US Plant After FDA Concerns: Report
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com
Teva Pharmaceutical Industries Ltd | Reuters
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ANJL4AXVTBOMDKS2X4DIJZXZAY.jpg "Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters")
Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OMAQFWFHNJDZCDZKKO5DWLBG4.jpg "Teva Israel enters medical cannabis market with new partnership | Reuters")
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva says vaccine makers have not taken its offer to help produce jabs | Financial Times
Teva Pharm woes seen denting Israeli exports, economic growth By Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceutical Industries Ltd | Reuters
Shloma Yanai (R), CEO of Teva Pharmaceutical Industries Ltd. and Hans-Joachim Ziems, chairman of VEM Holding exchange a handshake prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical Industries Ltd | Reuters
Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net
Teva Pharmaceuticals gets a coronavirus boost, but it won't last long - Business - Haaretz.com
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
